emtricitabine has been researched along with Age-Related Osteoporosis in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, J; Delgado, H; Do, D; Huynh, A; Kanimian, N | 1 |
| Badiou, S; Bado, G; Ciaffi, L; Cournil, A; Delaporte, E; Diouf, A; Eymard-Duvernay, S; Héma, A; Kabore, FN; Koulla-Shiro, S; Zoungrana, J | 1 |
| Anderson, PH; Ebeling, PR; Emery, S; Fairley, CK; Kimlin, MG; Klassen, KM | 1 |
| Lavae-Mokhtari, M; Mohammad-Khani, S; Schmidt, RE; Stoll, M | 1 |
| Daar, ES; Ha, B; Jahed, NC; Kitch, D; McComsey, GA; Melbourne, K; Myers, L; Sax, PE; Tebas, P; Tierney, C | 1 |
3 trial(s) available for emtricitabine and Age-Related Osteoporosis
| Article | Year |
|---|---|
TDF and quantitative ultrasound bone quality in African patients on second line ART, ANRS 12169 2LADY sub-study.
Topics: Adult; Antiretroviral Therapy, Highly Active; Bone and Bones; Bone Demineralization, Pathologic; Bone Density; Burkina Faso; Cameroon; Emtricitabine; Female; HIV Infections; HIV-1; Humans; Male; Middle Aged; Osteoporosis; Senegal; Tenofovir | 2017 |
Associations between vitamin D metabolites, antiretroviral therapy and bone mineral density in people with HIV.
Topics: Adult; Anti-HIV Agents; Body Mass Index; Bone Density; Calcitriol; Dideoxynucleosides; Drug Combinations; Emtricitabine; Female; Hip Joint; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Osteoporosis; Prospective Studies; Tenofovir; Vitamin D | 2016 |
Bone mineral density and fractures in antiretroviral-naive persons randomized to receive abacavir-lamivudine or tenofovir disoproxil fumarate-emtricitabine along with efavirenz or atazanavir-ritonavir: Aids Clinical Trials Group A5224s, a substudy of ACTG
Topics: Absorptiometry, Photon; Adenine; Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Benzoxazines; Bone Density; CD4 Lymphocyte Count; Cyclopropanes; Deoxycytidine; Dideoxynucleosides; Drug Combinations; Drug Therapy, Combination; Emtricitabine; Female; Fractures, Bone; HIV Infections; Humans; Intention to Treat Analysis; Lamivudine; Male; Middle Aged; Oligopeptides; Organophosphonates; Osteoporosis; Pyridines; Risk Factors; Ritonavir; Tenofovir; Viral Load | 2011 |
2 other study(ies) available for emtricitabine and Age-Related Osteoporosis
| Article | Year |
|---|---|
A retrospective analysis of bone loss in tenofovir-emtricitabine therapy for HIV PrEP.
Topics: Anti-HIV Agents; Bone Diseases, Metabolic; Emtricitabine; HIV Infections; Humans; Osteoporosis; Retrospective Studies; Tenofovir | 2022 |
[Acute renal failure and hypercalcemia in an AIDS patient on tenofovir and low-dose vitamin D therapy with immune reconstitution inflammatory syndrome].
Topics: Acquired Immunodeficiency Syndrome; Acute Kidney Injury; Adenine; Adrenal Cortex Hormones; Adult; AIDS-Related Opportunistic Infections; Alkynes; Anti-HIV Agents; Antitubercular Agents; Benzoxazines; Calcium; Cholecalciferol; Cyclopropanes; Deoxycytidine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Emtricitabine; Female; Humans; Hypercalcemia; Immune Reconstitution Inflammatory Syndrome; Kidney Function Tests; Mycobacterium avium-intracellulare Infection; Organophosphonates; Osteoporosis; Tenofovir | 2009 |